BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12610111)

  • 1. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.
    Gotoh B; Takeuchi K; Komatsu T; Yokoo J
    J Virol; 2003 Mar; 77(6):3360-70. PubMed ID: 12610111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition.
    Ramachandran A; Parisien JP; Horvath CM
    J Virol; 2008 Sep; 82(17):8330-8. PubMed ID: 18579593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.
    Lesinski GB; Valentino D; Hade EM; Jones S; Magro C; Chaudhury AR; Walker MJ; Carson WE
    Cancer Immunol Immunother; 2005 Sep; 54(9):815-25. PubMed ID: 15668815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses.
    Zimmermann A; Trilling M; Wagner M; Wilborn M; Bubic I; Jonjic S; Koszinowski U; Hengel H
    J Exp Med; 2005 May; 201(10):1543-53. PubMed ID: 15883169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.
    Testoni B; Völlenkle C; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
    J Biol Chem; 2011 Jun; 286(23):20217-27. PubMed ID: 21498520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.
    Christian SL; Collier TW; Zu D; Licursi M; Hough CM; Hirasawa K
    J Virol; 2009 Jul; 83(13):6717-26. PubMed ID: 19386709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins.
    Nanda SK; Baron MD
    J Virol; 2006 Aug; 80(15):7555-68. PubMed ID: 16840335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation.
    Chaudhary V; Zhang S; Yuen KS; Li C; Lui PY; Fung SY; Wang PH; Chan CP; Li D; Kok KH; Liang M; Jin DY
    J Gen Virol; 2015 Nov; 96(11):3204-3211. PubMed ID: 26353965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system.
    Wang J; Schreiber RD; Campbell IL
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16209-14. PubMed ID: 12461178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein.
    Liang X; Shin YC; Means RE; Jung JU
    J Virol; 2004 Nov; 78(22):12416-27. PubMed ID: 15507628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of alpha interferon signaling by hepatitis B virus.
    Christen V; Duong F; Bernsmeier C; Sun D; Nassal M; Heim MH
    J Virol; 2007 Jan; 81(1):159-65. PubMed ID: 17065208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.
    Ulane CM; Kentsis A; Cruz CD; Parisien JP; Schneider KL; Horvath CM
    J Virol; 2005 Aug; 79(16):10180-9. PubMed ID: 16051811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal genomic localization of STAT1 binding and regulated transcriptional activity.
    Wormald S; Hilton DJ; Smyth GK; Speed TP
    BMC Genomics; 2006 Oct; 7():254. PubMed ID: 17032459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interferon signaling by dengue virus.
    Muñoz-Jordan JL; Sánchez-Burgos GG; Laurent-Rolle M; García-Sastre A
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14333-8. PubMed ID: 14612562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha.
    Zimmerer JM; Lesinski GB; Radmacher MD; Ruppert A; Carson WE
    Cancer Immunol Immunother; 2007 Nov; 56(11):1845-52. PubMed ID: 17503042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection.
    Geary CD; Krishna C; Lau CM; Adams NM; Gearty SV; Pritykin Y; Thomsen AR; Leslie CS; Sun JC
    Cell Rep; 2018 Aug; 24(8):1949-1957.e6. PubMed ID: 30134157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon-α response in BCR::ABL1 negative myeloproliferative neoplasms.
    Ding L; Luo J; Du J; Zhao B; Luo J; Pan S; Zhang L; Yan X; Li J; Liu L
    Cancer Sci; 2023 Nov; 114(11):4445-4458. PubMed ID: 37681349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of porcine PK-15 cells lacking the Ifnar1 or Stat2 gene to optimize the efficiency of viral isolation.
    Shofa M; Saito A
    PLoS One; 2023; 18(11):e0289863. PubMed ID: 37939052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases.
    Bucciol G; Moens L; Ogishi M; Rinchai D; Matuozzo D; Momenilandi M; Kerrouche N; Cale CM; Treffeisen ER; Al Salamah M; Al-Saud BK; Lachaux A; Duclaux-Loras R; Meignien M; Bousfiha A; Benhsaien I; Shcherbina A; Roppelt A; ; Gothe F; Houhou-Fidouh N; Hackett SJ; Bartnikas LM; Maciag MC; Alosaimi MF; Chou J; Mohammed RW; Freij BJ; Jouanguy E; Zhang SY; Boisson-Dupuis S; Béziat V; Zhang Q; Duncan CJ; Hambleton S; Casanova JL; Meyts I
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 36976641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and Type II Interferon Antagonism Strategies Used by
    Pisanelli G; Pagnini U; Iovane G; García-Sastre A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.